Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections
- PMID: 15138241
- DOI: 10.1001/jama.291.18.2197
Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections
Abstract
Context: Historically, incidence of pneumococcal disease in the United States has been higher among blacks than among whites. Following recommendation of a new 7-valent pneumococcal conjugate vaccine for children in October 2000, the incidence of invasive pneumococcal disease has declined dramatically, but the impact of vaccination on racial disparities in incidence of pneumococcal disease is unknown.
Objective: To assess the effect of conjugate vaccine introduction on rates of pneumococcal disease among whites and blacks in the United States.
Design, setting, and patients: Analysis of data from the Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network, an active, population-based surveillance system in 7 states. Patients were 15,923 persons with invasive pneumococcal disease occurring between January 1, 1998, and December 31, 2002.
Main outcome measures: Age- and race-specific pneumococcal disease incidence rates (cases per 100 000 persons), rate ratios, and rate differences.
Results: Between 1998 and 2002, annual incidence rates for invasive pneumococcal disease decreased from 19.0 to 12.1 cases per 100 000 among whites and from 54.9 to 26.5 among blacks. Due to these declines, 14,730 fewer cases occurred among whites and 8780 fewer cases occurred among blacks in the United States in 2002, compared with 2 prevaccine years, 1998 and 1999. Before vaccine introduction, incidence among blacks was 2.9 times higher than among whites (95% confidence interval [CI], 2.7-3.0); in 2002, the black-white rate ratio had been reduced to 2.2 (95% CI, 2.0-2.4). Incidence among black children younger than 2 years went from being 3.3 times higher (95% CI, 3.0-3.7) than among white children in the prevaccine period to 1.6 times higher (95% CI, 1.1-2.2) in 2002. By 2002, 74% of white children and 68% of black children aged 19 to 35 months in the 7 states had received at least 1 dose of pneumococcal conjugate vaccine; 43% of white and 39% of black children received 3 or more doses.
Conclusion: Although blacks remain at higher risk of invasive pneumococcal disease, introduction of childhood pneumococcal vaccination has reduced the racial disparity in incidence of pneumococcal disease.
Comment in
-
Race-based immunization recommendations and the potential to reduce health disparities.JAMA. 2004 May 12;291(18):2253-5. doi: 10.1001/jama.291.18.2253. JAMA. 2004. PMID: 15138248 No abstract available.
Similar articles
-
Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era.JAMA. 2001 Apr 4;285(13):1729-35. doi: 10.1001/jama.285.13.1729. JAMA. 2001. PMID: 11277827
-
Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine.Pediatr Infect Dis J. 2005 Jan;24(1):17-23. doi: 10.1097/01.inf.0000148891.32134.36. Pediatr Infect Dis J. 2005. PMID: 15665705
-
Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.JAMA. 2007 Apr 25;297(16):1784-92. doi: 10.1001/jama.297.16.1784. JAMA. 2007. PMID: 17456820
-
Pneumococcal vaccines: do they prevent infection and how?Curr Opin Infect Dis. 2004 Jun;17(3):177-84. doi: 10.1097/00001432-200406000-00002. Curr Opin Infect Dis. 2004. PMID: 15166818 Review.
-
A conjugate vaccine for the prevention of pediatric pneumococcal disease.Mil Med. 2002 Aug;167(8):671-7. Mil Med. 2002. PMID: 12188240 Review.
Cited by
-
Conjugate vaccines.Arch Dis Child. 2005 Jul;90(7):667-9. doi: 10.1136/adc.2005.072173. Arch Dis Child. 2005. PMID: 15970605 Free PMC article. Review. No abstract available.
-
Clonal association between Streptococcus pneumoniae serotype 23A, circulating within the United States, and an internationally dispersed clone of serotype 23F.J Clin Microbiol. 2005 Nov;43(11):5440-4. doi: 10.1128/JCM.43.11.5440-5444.2005. J Clin Microbiol. 2005. PMID: 16272467 Free PMC article.
-
Changing disparities in invasive pneumococcal disease by socioeconomic status and race/ ethnicity in Connecticut, 1998-2008.Public Health Rep. 2011 Sep-Oct;126 Suppl 3(Suppl 3):81-8. doi: 10.1177/00333549111260S313. Public Health Rep. 2011. PMID: 21836741 Free PMC article.
-
Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.N Engl J Med. 2009 Jan 15;360(3):244-56. doi: 10.1056/NEJMoa0800836. N Engl J Med. 2009. PMID: 19144940 Free PMC article.
-
Racial and Regional Differences in Rates of Invasive Pneumococcal Disease.Pediatrics. 2015 Nov;136(5):e1186-94. doi: 10.1542/peds.2015-1773. Epub 2015 Oct 12. Pediatrics. 2015. PMID: 26459652 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical